15.5TWD
4.11 BTWD
16.96 BTWD
150.80 M
About LOTUS PHARMACEUTICAL CO
Sector
CEO
Petar Antonov Vazharov
Headquarters
Taipei
Website
Founded
1966
ISIN
TW0001795003
FIGI
BBG0015S6316
Lotus Pharmaceutical Co., Ltd. engages in the research and development, manufacturing, and sales of generic pharmaceutical products; and the provision of consulting services. It operates under the Generic Drug and Other business segments. The Generic Drug segment focuses on generic pharmaceutical products. The Other segment provides clinical trial and technical services. The company was founded on June 30, 1966 and is headquartered in Taipei, Taiwan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 1795 is 334.00 TWD — it has increased by 0.45% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange LOTUS PHARMACEUTICAL CO stocks are traded under the ticker 1795.
LOTUS PHARMACEUTICAL CO is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for LOTUS PHARMACEUTICAL CO has a max estimate of 600.00 TWD and a min estimate of 275.00 TWD.
1795 earnings for the last quarter are 4.74 TWD whereas the estimation was 4.60 TWD which accounts for 2.95% surprise. Estimated earnings for the next quarter are 1.47 TWD. See more details about LOTUS PHARMACEUTICAL CO earnings.
LOTUS PHARMACEUTICAL CO revenue for the last quarter amounts to 4.57 B TWD despite the estimated figure of 4.53 B TWD. In the next quarter revenue is expected to reach 3.60 B TWD.
Yes, you can track LOTUS PHARMACEUTICAL CO financials in yearly and quarterly reports right on TradingView.
Like other stocks, 1795 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LOTUS PHARMACEUTICAL CO stock right from TradingView charts — choose your broker and connect to your account.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LOTUS PHARMACEUTICAL CO EBITDA is 6.11 B TWD, and current EBITDA margin is 36.05%. See more stats in LOTUS PHARMACEUTICAL CO financial statements.